South African pharmaceuticals company Ascendis Health’s board of directors continues to consider nonbinding proposals and expressions of interest (EoIs) for the acquisition of Ascendis Health shares. The company on November 12 said it continues to receive a number of these, though it advised shareholders that they should “base their investment decisions regarding Ascendis Health shares on announcements published by the company itself and not on information from other sources”, as that information may not necessarily be accurate or based on “a complete set of facts”.
from Engineering News | Home https://ift.tt/3kx6w1o
